Connection

Pilar Escribano Subías to Humans

This is a "connection" page, showing publications Pilar Escribano Subías has written about Humans.
Connection Strength

0.151
  1. COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match? Ann Am Thorac Soc. 2021 06; 18(6):1080-1081.
    View in: PubMed
    Score: 0.008
  2. Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19. Sci Rep. 2020 11 16; 10(1):19893.
    View in: PubMed
    Score: 0.007
  3. Giant T Wave Inversion and Dyspnea in the Time of Coronavirus Pandemic. Circulation. 2020 09; 142(9):906-909.
    View in: PubMed
    Score: 0.007
  4. Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients. Arch Bronconeumol (Engl Ed). 2020 Nov; 56(11):749-752.
    View in: PubMed
    Score: 0.007
  5. Clinical course of COVID-19 in pulmonary arterial hypertension patients. Rev Esp Cardiol (Engl Ed). 2020 09; 73(9):775-778.
    View in: PubMed
    Score: 0.007
  6. Inverse cardiac tamponade in severe pulmonary hypertension. Med Clin (Barc). 2020 04 10; 154(7):287.
    View in: PubMed
    Score: 0.007
  7. Management of incidentally diagnosed pulmonary artery dissection in patients with pulmonary arterial hypertension. Eur J Cardiothorac Surg. 2019 Jul 01; 56(1):210-212.
    View in: PubMed
    Score: 0.007
  8. Does the composition of polystyrene trays affect Candida spp. biofilm formation? Med Mycol. 2019 Jun 01; 57(4):504-509.
    View in: PubMed
    Score: 0.007
  9. Frequency, Predictors, and Prognostic Impact of Pulmonary Artery Aneurysms in Patients With Pulmonary Arterial Hypertension. Am J Cardiol. 2019 02 01; 123(3):474-481.
    View in: PubMed
    Score: 0.006
  10. Reduction in Percentage of Clusters of Candida albicans and Candida parapsilosis Causing Candidemia in a General Hospital in Madrid, Spain. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0.006
  11. Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension. Observational Study in a Referral Unit. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):224-232.
    View in: PubMed
    Score: 0.006
  12. Letter by Hernandez-Gonzalez et al Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension". Circulation. 2018 05 29; 137(22):2411-2412.
    View in: PubMed
    Score: 0.006
  13. Surrogate Endpoints for Pulmonary Hypertension Management and Trial Design: Moving in the Right Direction. J Am Coll Cardiol. 2018 02 20; 71(7):764-765.
    View in: PubMed
    Score: 0.006
  14. Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations. Arch Bronconeumol (Engl Ed). 2018 Apr; 54(4):205-215.
    View in: PubMed
    Score: 0.006
  15. Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization. J Am Coll Cardiol. 2017 11 07; 70(19):2459-2460.
    View in: PubMed
    Score: 0.006
  16. Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival. Rev Esp Cardiol (Engl Ed). 2018 Feb; 71(2):86-94.
    View in: PubMed
    Score: 0.006
  17. The Etest Performed Directly on Blood Culture Bottles Is a Reliable Tool for Detection of Fluconazole-Resistant Candida albicans Isolates. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.006
  18. Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre. Rev Esp Cardiol (Engl Ed). 2017 Nov; 70(11):915-923.
    View in: PubMed
    Score: 0.006
  19. Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob Agents Chemother. 2013 Jun; 57(6):2815-20.
    View in: PubMed
    Score: 0.004
  20. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic. Orphanet J Rare Dis. 2021 05 01; 16(1):196.
    View in: PubMed
    Score: 0.002
  21. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity. Mycoses. 2021 Feb; 64(2):132-143.
    View in: PubMed
    Score: 0.002
  22. Outbreak of COVID-19 in a nursing home in Madrid. J Infect. 2020 10; 81(4):647-679.
    View in: PubMed
    Score: 0.002
  23. A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis. Med Mycol. 2020 Apr 01; 58(3):300-309.
    View in: PubMed
    Score: 0.002
  24. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial. Eur Respir J. 2019 10; 54(4).
    View in: PubMed
    Score: 0.002
  25. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis. Mycoses. 2019 May; 62(5):441-449.
    View in: PubMed
    Score: 0.002
  26. Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry. Int J Cardiol. 2019 Jan 15; 275:158-164.
    View in: PubMed
    Score: 0.002
  27. A new cause of false positive voriconazole levels: Watch your collection tubes! J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15; 1092:328-331.
    View in: PubMed
    Score: 0.002
  28. Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples. Antimicrob Agents Chemother. 2018 06; 62(6).
    View in: PubMed
    Score: 0.002
  29. Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates. Antimicrob Agents Chemother. 2018 03; 62(3).
    View in: PubMed
    Score: 0.002
  30. Selection of the Best of 2017 in Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed). 2018 Apr; 71(4):299-300.
    View in: PubMed
    Score: 0.001
  31. Inonotosis in Patient with Hematologic Malignancy. Emerg Infect Dis. 2018 01; 24(1):180-182.
    View in: PubMed
    Score: 0.001
  32. Lung and heart-lung transplantation in pulmonary arterial hypertension. PLoS One. 2017; 12(11):e0187811.
    View in: PubMed
    Score: 0.001
  33. 2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension. Semin Arthritis Rheum. 2018 06; 47(6):870-876.
    View in: PubMed
    Score: 0.001
  34. The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp. J Antimicrob Chemother. 2017 07 01; 72(7):1969-1976.
    View in: PubMed
    Score: 0.001
  35. Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.001
  36. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLoS One. 2017; 12(6):e0179136.
    View in: PubMed
    Score: 0.001
  37. Pulmonary endarterectomy outputs in chronic thromboembolic pulmonary hypertension. Med Clin (Barc). 2017 Jul 07; 149(1):1-8.
    View in: PubMed
    Score: 0.001
  38. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin. Antimicrob Agents Chemother. 2013 Nov; 57(11):5767-70.
    View in: PubMed
    Score: 0.001
  39. Molecular epidemiology of Aspergillus fumigatus: an in-depth genotypic analysis of isolates involved in an outbreak of invasive aspergillosis. J Clin Microbiol. 2011 Oct; 49(10):3498-503.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.